8
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Trilineage Response to rhG-CSF with Subsequent Clonal Hematopoiesis in a Patient with Severe Bone Marrow Aplasia

, , , , , & show all
Pages 347-351 | Received 09 Sep 1993, Published online: 01 Jul 2009

References

  • Camitta B. M., Strobe R., Thomas E. D. Aplastic anemia: pathogenesis, diagnosis, treatment, and prognosis. N. Engl. J. Med. 1982; 306: 645–652
  • Lieschke G. J., Burgess A. W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony stimulating factor (second of two parts). N. Engl. J. Med. 1992; 327: 99–106
  • Bertrand Y., Amri F., Capdeville R., Ffrench M., Philippe N. The successful treatment of two cases of severe aplastic anemia with granulocyte-colony stimulating factor and cyclosporine A. Br. J. Haematol. 1991; 79: 648–652
  • Washizuka T., Koike T., Toba K., Nagai K., Takahashi M., Shibata A. A rise of erythrocytes and platelets in a patient with myelodysplastic syndrome during the administration of G-CSF. Am. J. Hematol. 1992; 39: 153–154
  • Sonoda Y., Yashige H., Fujii H., Tsuda S., Maekawa T., Misawa S., Abe T. Bilineage response in refractory aplastic anemia patients following long-term administration of recombinant human granulocyte colony-stimulating factor. Eur. J. Haematol. 1992; 48: 41–48
  • Bessho M., Itoh Y., Kataumi S., Kawai N., Matsuda A., Jinnai I., Saitoh M., Hirashima K., Minamihisamatsu M. A hematological remission by clonal hematopoiesis after treatment with recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin in a patient with therapy-related myelodysplastic syndrome. Leukemia Res. 1992; 16: 123–131
  • Vadhan-Raj S., Borxmeyer H. E., Spizer G., Le Maistre A., Hultman S., Ventura G., Tigaud J. D., Cork M. A., Trujillo J. M., Gutterman J. U., Hittelman W. N. Stimulation of nonclonal hematopoiesis and suppression of the neoplastic clone after treatment with recombinant human granulocyte-macrophage colony-stimulating factor in a patient with therapy-related myelodysplastic syndrome. Blood 1989; 74: 1491–1498
  • Kojima S., Fukuda M., Miyajima Y., Matsuyama T., Horibe K. Treatment of aplastic anemia in children with recombinant human granulocyte colony-stimulating factor. Blood 1991; 77: 937–941
  • Vadhan-Raji S., Buescher S., Broxmeyer H. E., Le Maistre A., Lepe-Zuniga J. L., Ventura G., Jeha S., Horwitz L. J., Trujillo J. M., Gillis S., Hittelman W. N., Gutterman J. U. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. N. Engl. J. Med. 1988; 319: 1628–1634
  • Vogelstein B., Fearon E. R., Hamilton S. R., Preisinger A. C., Eillard H. F., Michelson A. M., Riggs A. D., Orkin S. H. Clonal analysis using recombinant DNA probes from X-chromosome. Cancer Res. 1987; 47: 4806–4813
  • Tamura M., Hattori K., Nomura H., Oheda M., Kubota N., Imazeki I., Ono M., Ueyama Y., Nagata S., Shirafuji N., Asano S. Induction of neutrophilic granulocytosis in mice by administration of purified human native granulocyte colony-stimulating factor (G-CSF). Biochem. Biophys. Res. Commun. 1987; 142: 454–460
  • Vellenga E., Yung D. C., Wagner K., Wiper C., Ostapovicz D., Griffin J. D. The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood 1987; 69: 1771–1776
  • Budel L. M., Touw I. P., Delwel R., Lowenbery B. Granulocyte colony-stimulating factor receptors in human acute myelocytic leukemia. Blood 1989; 74: 2668–2673
  • Tricot G., Mecucci C., Ban den Berghe H. Evolution of the myelodysplastic syndromes. Br. J. Haematol. 1986; 63: 609–614
  • Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C., French-American-British (FAB) Co-Operative Group. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982; 51: 189–199

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.